Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Acq. announced
Talon Therapeutics, Inc. (TLON) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/28/2017 CT ORDER Form CT ORDER - Confidential treatment order
12/29/2016 CT ORDER Form CT ORDER - Confidential treatment order
07/29/2013 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
07/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
07/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
07/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
07/19/2013 8-K Quarterly results
07/18/2013 4 WEATHERMAN ELIZABETH H (Director) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Converted 65,016,890 shares @ $0.736, valued at $47.9M
Converted 37,775,503 shares @ $0.3, valued at $11.3M
Converted 49,537,551 shares @ $0.35, valued at $17.3M
Sold 152,329,944 shares @ $0.06, valued at $9.1M
Converted 360,000 options to buy @ $100, valued at $36M
Converted 11,307 preferred shares @ $100, valued at $1.1M
Converted 99,000 options to buy @ $100, valued at $9.9M
Converted 27,000 options to buy @ $100, valued at $2.7M
Converted 54,000 options to buy @ $100, valued at $5.4M
Disposed of 420,000 options to buy @ $0
07/18/2013 4 WARBURG PINCUS & CO. (10% Owner) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Converted 65,016,890 shares @ $0.736, valued at $47.9M
Converted 37,775,503 shares @ $0.3, valued at $11.3M
Converted 49,537,551 shares @ $0.35, valued at $17.3M
Sold 152,329,944 shares @ $0.056, valued at $8.5M
Converted 360,000 options to buy @ $100, valued at $36M
Converted 11,307 preferred shares @ $100, valued at $1.1M
Converted 99,000 options to buy @ $100, valued at $9.9M
Converted 27,000 options to buy @ $100, valued at $2.7M
Converted 54,000 options to buy @ $100, valued at $5.4M
Disposed of 420,000 options to buy @ $0
07/18/2013 SC 13D/A Warburg Pincus Private Equity X, L.P. reports a 0% stake in Talon Therapeutics, Inc.
07/18/2013 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/18/2013 4 Flynn James E (10% Owner) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Converted 424,798 shares @ $0.736, valued at $312.7k
Converted 837,215 shares @ $0.3, valued at $251.2k
Converted 322,911 shares @ $0.35, valued at $113k
Sold 1,619,176 shares @ $0.0561, valued at $90.8k
Converted 778,856 shares @ $0.736, valued at $573.2k
Converted 1,535,573 shares @ $0.3, valued at $460.7k
Converted 592,613 shares @ $0.35, valued at $207.4k
Sold 2,974,566 shares @ $0.0561, valued at $166.9k
Converted 2,305,753 shares @ $0.736, valued at $1.7M
Converted 4,545,880 shares @ $0.3, valued at $1.4M
Converted 1,757,664 shares @ $0.35, valued at $615.2k
07/18/2013 4 Spiegel Robert J. (Director) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Disposed/sold 10,000 options to buy @ $0.68, valued at $6.8k
Disposed/sold 35,000 options to buy @ $0.77, valued at $27k
Disposed/sold 35,000 options to buy @ $0.905, valued at $31.7k
Disposed/sold 35,000 options to buy @ $0.64, valued at $22.4k
07/18/2013 4 Rosenberg Leon E (Director) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Disposed/sold 250 shares @ $0
Disposed/sold 7,050 options to buy @ $6.736, valued at $47.5k
Disposed/sold 5,000 options to buy @ $5.32, valued at $26.6k
Disposed/sold 5,000 options to buy @ $6.6, valued at $33k
Disposed/sold 10,000 options to buy @ $19, valued at $190k
Disposed/sold 10,000 options to buy @ $27.28, valued at $272.8k
Disposed/sold 8,750 options to buy @ $8.16, valued at $71.4k
Disposed/sold 18,750 options to buy @ $4.48, valued at $84k
Disposed/sold 18,750 options to buy @ $0.56, valued at $10.5k
Disposed/sold 18,750 options to buy @ $0.76, valued at $14.3k
Disposed/sold 65,000 options to buy @ $0.77, valued at $50.1k
07/18/2013 4 PIEN HOWARD H (Director) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Disposed/sold 50,000 options to buy @ $0.82, valued at $41k
Disposed/sold 35,000 options to buy @ $0.64, valued at $22.4k
07/18/2013 4 MAIER PAUL V (Director) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Disposed/sold 1,750 shares @ $0
Disposed/sold 10,000 options to buy @ $3.6, valued at $36k
Disposed/sold 2,500 options to buy @ $2.92, valued at $7.3k
Disposed/sold 12,500 options to buy @ $0.56, valued at $7k
Disposed/sold 12,500 options to buy @ $0.76, valued at $9.5k
Disposed/sold 47,000 options to buy @ $0.77, valued at $36.2k
Disposed/sold 47,000 options to buy @ $0.905, valued at $42.5k
Disposed/sold 47,000 options to buy @ $0.64, valued at $30.1k
07/18/2013 4 Gharib Samir M. (Controller, Direct. of Finance) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Disposed/sold 75,000 options to buy @ $0.485, valued at $36.4k
Disposed/sold 50,000 options to buy @ $0.64, valued at $32k
07/18/2013 4 Furst Howard P. (Director) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Disposed/sold 10,000 options to buy @ $0.76, valued at $7.6k
Disposed/sold 35,000 options to buy @ $0.77, valued at $27k
Disposed/sold 35,000 options to buy @ $0.905, valued at $31.7k
Disposed/sold 35,000 options to buy @ $0.64, valued at $22.4k
07/18/2013 4 DeZao Thomas (VP, Comm. Oper. & Planning) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Disposed/sold 200,000 options to buy @ $0.745, valued at $149k
Disposed/sold 100,000 options to buy @ $0.64, valued at $64k
07/18/2013 4 DEITCHER STEVEN R (President & CEO) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Disposed/sold 184,192 shares @ $0
Disposed/sold 100,000 options to buy @ $6.6, valued at $660k
Disposed/sold 25,000 options to buy @ $6.96, valued at $174k
Disposed/sold 162,500 options to buy @ $4.48, valued at $728k
Disposed/sold 75,000 options to buy @ $0.56, valued at $42k
Disposed/sold 312,500 options to buy @ $0.76, valued at $237.5k
Disposed/sold 87,500 options to buy @ $0.92, valued at $80.5k
Disposed/sold 1,635,000 options to buy @ $0.495, valued at $809.3k
Disposed/sold 1,000,000 options to buy @ $0.905, valued at $905k
Disposed/sold 1,000,000 options to buy @ $0.64, valued at $640k
07/18/2013 4 CARLSON CRAIG W (CFO) has filed a Form 4 on Talon Therapeutics, Inc.
Txns: Disposed/sold 87,500 options to buy @ $0.76, valued at $66.5k
Disposed/sold 62,500 options to buy @ $0.92, valued at $57.5k
Disposed/sold 705,000 options to buy @ $0.495, valued at $349k
Disposed/sold 400,000 options to buy @ $0.905, valued at $362k
Disposed/sold 400,000 options to buy @ $0.64, valued at $256k
07/17/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Spectrum Pharmaceuticals Acquires Talon Therapeutics South San Francisco, Calif., July 17, 2013 – Talon Therapeutics, Inc. today announced that a subsidiary of Spectrum Pharmaceuticals, Inc. entered into an agreement to purchase approximately 89% of the outstanding shares of Talon directly from the Company’s principal stockholders. Spectrum also entered into an agreement with the Company under which the subsidiary of Spectrum will purchase additional shares from the Company that, together with the shares acquired from the Company’s principal stockholders, will represent in excess of 90% of the outstanding shares of Talon, and under which Spectrum will acquire the remaining outstanding shares of Company common stock through a “short-form” merger of the subsidiary of Spectrum into the Compan..."
05/15/2013 10-Q Quarterly Report for the period ended March 31, 2013
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy